Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
700.00    0.00 (0.00%)
Bid:
690.00
Ask:
710.00
Spread: 20.00 (2.899%)
Market Cap: £246.67m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

New Investment

22 Sep 2025 15:23

RNS Number : 3004A
B.P. Marsh & Partners PLC
22 September 2025
 

22 September 2025

 

B.P. Marsh & Partners Plc

("B.P. Marsh", "the Company" or "the Group")

 

New Investment - Salus Capital Partners Limited ("Salus")

 

B.P. Marsh & Partners Plc (AIM: BPM), the specialist private equity investor in early-stage financial services businesses, is pleased to announce that it has acquired a 35% Cumulative Preferred Ordinary shareholding in Salus, a start-up UK-based insurance intermediary group, specialising in Professional Indemnity insurance.

 

B.P. Marsh has agreed to provide funding of up to £2m, via a mixture of equity and a loan facility. The loan facility was partially drawn down upon completion.

 

Salus will operate via two subsidiaries, Forte Professions Limited ("Forte") and Scribe MGA Limited ("Scribe").

Forte is a specialist Professional Indemnity insurance broker, targeting UK-domiciled businesses including Architects, Engineers, Construction, Surveyors, Accountants and Insurance Brokers.

 

Scribe, the underwriting unit of Salus, specialises in Professional Indemnity insurance for small to medium-sized businesses, with an initial focus on Construction, Surveyors and Accountancy. Salus has been founded by four experienced industry practitioners, James Page, Matthew Jones, Dawn Zacharow and Stuart Barker whose collective experience in insurance broking and underwriting within the Professional Indemnity market approaches 100 years.

 

With the backing of B.P. Marsh, the Salus team is committed to establishing a premier, client-focused brokerage and underwriting agency, headquartered in Bristol, providing its clients with access to the speciality Broking and Underwriting services they require.

 

Sophia Gooddy, Associate Director at B.P. Marsh, will be appointed to the Board of Salus alongside Chief Investment Officer, Dan Topping.

 

Dan Topping commented:

 

"We are pleased to be making this investment in Salus, founded by a highly skilled and experienced Management team.

 

"B.P. Marsh looks forward to working with the co-founders to deliver on their business plan of building a successful Professional Indemnity brokerage and underwriting agency.

 

"We believe Salus is an excellent fit for our diversified investment portfolio of insurance intermediaries."

 

James Page, Matthew Jones, Dawn Zacharow and Stuart Barker, the founders of Salus, commented:

 

"We are delighted to partner with B.P. Marsh as we pursue our long-term ambitions, as set out in our business plan.

 

"B.P. Marsh offers Salus more than a financial investment, and the team brings a significant amount of insurance experience, expertise, and relationships. We look forward to working with B.P. Marsh over the years to come to achieve our goals."

 

For further information on B.P. Marsh, its strategy and current portfolio, please visit www.bpmarsh.co.uk or contact: 

 

B.P. Marsh & Partners Plc

Brian Marsh OBE / Alice Foulk

 

+44 (0)20 7233 3112

Nominated Adviser & Joint Corporate Broker:

Panmure Liberum Limited

David Watkins / Atholl Tweedie / Amrit Mahbubani

 

 

+44 (0)20 7886 2500

Joint Corporate Broker:

Singer Capital Markets Advisory LLP

Charles Leigh Pemberton / James Moat / Asha Chotai

 

+44 (0)20 7496 3000

Financial PR & Investor Relations:

Tavistock

Simon Hudson / Katie Hopkins / Kuba Stawiski

 

bpmarsh@tavistock.co.uk

+44 (0)20 7920 3150

 

-Ends-

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFFSALIFFIE
Date   Source Headline
23rd Sep 20257:00 amRNSTrading Update
22nd Sep 20253:23 pmRNSNew Investment
12th Sep 20257:00 amRNSNew Investment: Supporting the Growth of XPT Group
29th Aug 20253:54 pmRNSNew Investment - Supporting the Growth of Pantheon
22nd Aug 20252:32 pmRNSDirector/PDMR Shareholding
14th Aug 20257:00 amRNSNew Investment- supporting the growth of XPT Group
11th Aug 202512:50 pmRNSHolding(s) in Company
11th Aug 202510:35 amRNSHolding(s) in Company
11th Aug 202510:35 amRNSHolding(s) in Company
7th Aug 202512:44 pmRNSHolding(s) in Company
7th Aug 20257:05 amRNSBuyback Results, Transaction in Own Shares and TVR
7th Aug 20257:00 amRNSResult of Secondary Placing
6th Aug 20254:51 pmRNSProposed Buyback
6th Aug 20254:40 pmRNSPROPOSED SECONDARY PLACING
4th Aug 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
31st Jul 20258:05 amRNSPurchase of Own Shares and Total Voting Rights
17th Jul 202512:31 pmRNSResult of AGM
16th Jul 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
15th Jul 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
14th Jul 20252:10 pmRNSHolding(s) in Company
14th Jul 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
11th Jul 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
3rd Jul 20254:30 pmRNSHolding(s) in Company
1st Jul 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
30th Jun 20257:00 amRNSPurchase of Own Shares
30th Jun 20257:00 amRNSFollow-on equity purchase in and loan to Pantheon
24th Jun 20251:15 pmRNSNotice of AGM - correction
24th Jun 202511:39 amRNSNotice of AGM
20th Jun 202510:13 amRNSPurchase of Own Shares and Total Voting Rights
17th Jun 20257:00 amRNSNew Investment – Cameron Specialty HoldCo Limited
12th Jun 202512:30 pmRNSDirector/PDMR Shareholding
11th Jun 20254:18 pmRNSDirector/PDMR Shareholding
11th Jun 20253:33 pmRNSHolding(s) in Company
10th Jun 20254:45 pmRNSDirector/PDMR Shareholding
10th Jun 202511:30 amRNSFinal Dividend Declaration
10th Jun 20257:00 amRNSFinal Results for the Year to 31 January 2025
5th Jun 202511:15 amRNSSale of Interest in Sterling Insurance Pty Ltd
4th Jun 20252:45 pmRNSNew Investment - Amiga Speciality Holdings Limited
4th Jun 202512:23 pmRNSNotice of Annual Results and Investor Presentation
3rd Jun 202511:44 amRNSResult of Meeting
14th May 20255:34 pmRNSHolding(s) in Company
14th May 20254:53 pmRNSHolding(s) in Company
12th May 20253:17 pmRNSSecondary Share Sale
12th May 202512:15 pmRNSShare BuyBack, Notice of GM and Rule 9 Waiver
9th May 202512:49 pmRNSResult of Secondary Placing
8th May 20254:40 pmRNSProposed Secondary Placing
24th Apr 20259:59 amRNSDirector/PDMR Shareholding
23rd Apr 20257:00 amRNSNew Investment - iO Partners
17th Apr 20251:45 pmRNSNew Share Buyback Programme
16th Apr 20254:45 pmRNSSpecial Dividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.